---
title: "Fuxin Technology released its first-quarter performance, with a net profit attributable to the parent company of 7.03 million yuan, a year-on-year decrease of 18.17%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237373411.md"
description: "According to the Zhitong Finance APP, Fuxin Technology disclosed its first-quarter report for 2025, showing that the company achieved revenue of 112 million yuan during the reporting period, a year-on-year increase of 4.08%; the net profit attributable to the parent company was 7.03 million yuan, a year-on-year decrease of 18.17%; the net profit excluding non-recurring gains and losses was 6.42 million yuan, a year-on-year decrease of 22.59%. The basic earnings per share were 0.08 yuan"
datetime: "2025-04-24T11:55:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237373411.md)
  - [en](https://longbridge.com/en/news/237373411.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237373411.md)
generator: "portal-rs"
---

# Fuxin Technology released its first-quarter performance, with a net profit attributable to the parent company of 7.03 million yuan, a year-on-year decrease of 18.17%

According to the Zhitong Finance APP, Fuxin Technology (688662.SH) disclosed its first-quarter report for 2025, showing that the company achieved revenue of 112 million yuan during the reporting period, a year-on-year increase of 4.08%; net profit attributable to shareholders was 7.03 million yuan, a year-on-year decrease of 18.17%; and net profit excluding non-recurring items was 6.42 million yuan, a year-on-year decrease of 22.59%. Basic earnings per share were 0.08 yuan

### Related Stocks

- [688662.CN](https://longbridge.com/en/quote/688662.CN.md)

## Related News & Research

- [Brandenburg Kapital joins AssistMe’s EUR 6.5 million financing round](https://longbridge.com/en/news/297893934.md)
- [11:07 ETEMQX Enterprise 6.3 Long-Term Support Release Strengthens Security for Production MQTT Deployments](https://longbridge.com/en/news/297933790.md)
- [TP: Monthly Information Regarding Shares and Voting Rights](https://longbridge.com/en/news/297678327.md)
- [Egetis says new Emcitate clinical data from Triac Trial II, ReTRIACt to be presented at September congresses](https://longbridge.com/en/news/297996002.md)
- [India's Hexaware falls after abrupt CEO exit](https://longbridge.com/en/news/297857400.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**